Improving the In Vivo Efficacy of an Anti-Tac (CD25) Immunotoxin by Pseudomonas Exotoxin A Domain II Engineering.
Mol Cancer Ther
; 17(7): 1486-1493, 2018 07.
Article
in En
| MEDLINE
| ID: mdl-29695631
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bacterial Toxins
/
Protein Engineering
/
ADP Ribose Transferases
/
Hematologic Neoplasms
/
Virulence Factors
/
Exotoxins
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2018
Type:
Article